Publications

Recent publications

Please click the links for further details

1. 1. Practical progress towards the development of recombinant antivenoms for snakebite envenoming (Review)
   2. De novo designed proteins neutralize lethal snake venom toxins
   3. African polyvalent antivenom can maintain pharmacological stability and ability to neutralise murine venom lethality for decades post-expiry: evidence for increasing antivenom shelf life to aid in alleviating chronic shortages
   4. Synthetic development of a broadly neutralizing antibody against snake venom long-chain α-neurotoxins
   5. ADDovenom: Thermostable Protein-Based ADDomer Nanoparticles as New Therapeutics for Snakebite Envenoming
   6. Next-Generation Sequencing for Venomics: Application of Multi-Enzymatic Limited Digestion for Inventorying the Snake Venom Arsenal
   7. Two snakebite antivenoms have potential to reduce Eswatini’s dependency upon a single, increasingly unavailable product: Results of preclinical efficacy testing
   8. Virus-like particles displaying conserved toxin epitopes stimulate polyspecific, murine antibody responses capable of snake venom recognition
   9. Exploring the Utility of Recombinant Snake Venom Serine Protease Toxins as Immunogens for Generating Experimental Snakebite Antivenoms
   10. In vitro and in vivo preclinical venom inhibition assays identify metalloproteinase inhibiting drugs as potential future treatments for snakebite envenoming by Dispholidus typus
   11. Twelve lateral flow immunoassays (LFAs) to detect SARS-CoV-2 antibodies
   12. SARS-CoV-2 enzyme-linked immunosorbent assays as proxies for plaque reduction neutralisation tests